Anavex Life Sciences Corp (AVXL)

[McMagyar]

You should do both..Larger Trial with Efficacy focus.. but
I don't disagree as HAM D was initially taken as just a Base and then added to the Regular Testing after so many Positive Effects were related by Patients and Caregivers.
Do you see separate testing altogether for Insomnia?

Insomnia is a Major Cause/SIGN of Multiple diseases and deserves it's own
Data altogether. You would fill an Insomniac Patient Phase 2 in about 3 days wherever you had it. Who doesn't have trouble sleeping!
It would not hurt the Market Place to know the depth of
Sleeping Comfort that A2-73 brings to patients.
What percentage of Insomniac Population showed relief would be my big question? That 8 Point reduction..was that 4 patients at 2 pts off of 20 patients that had insomnia issues.. or was it 1 point from 8 Patients that showed 4 points of insomnia issues..
And in the overall scheme, do any of the ACDS-DL questions refer to sleep and were those scores generally improved?
With Anavex's Safety Profile..and Alzheimers having a 99% FAIL Rate..
An expansion of the IND into a Daily and More Common health Isuue, could reduce the cost of Future Capital dramatically as it could reduce the risk factor of success.
A Non-Addictive, Non-Narcotic, Non-Drowsy SLEEP AID you take once a day.
BLOCKBUSTER